Drupal.behaviors.print = function(context) {window.print();window.close();}>
Dx Focus: Quest Simplexa C. Diff Assay Gets FDA OK; XDx Begins AlloMap Testing in Germany
April 12, 2012
Dx Focus: Quest Simplexa C. Diff Assay Gets FDA OK; XDx Begins AlloMap Testing in Germany
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
PCR Probe Licensing Pact with Focus Diagnostics Portends 'Busy Year' for Evogen
March 14, 2013 / PCR Insider
FDA Clears Quest's C. difficile Molecular Test
April 11, 2012 / GenomeWeb Daily News
Dx Focus: OraSure Gets FDA OK for DNA Collection Device; Quest Dengue Test Approved in Brazil
December 8, 2011 / PCR Insider
Quest's Focus Diagnostics Launches Nucleic Acid Extraction-Free Flu/RSV Test in Europe
November 3, 2011 / PCR Insider
Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
May 5, 2011 / PCR Insider